Capstone Wealth Management (Alabama)’s AbbVie ABBV Stock Holding History

Capstone Wealth Management (Alabama)’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$335K	Buy	1,330 +26	+2%	+$5.59K	0.16%	102
2026 Q1	$284K	Sell	1,304 -10	-0.8%	-$2.22K	0.2%	45
2025 Q4	$300K	Sell	1,314 -132	-9%	-$30.1K	0.22%	42
2025 Q3	$335K	Buy	1,446 +8	+0.6%	+$1.63K	0.26%	40
2025 Q2	$267K	Buy	1,438 +161	+13%	+$29.9K	0.23%	42
2025 Q1	$267K	Sell	1,277 -18	-1%	-$3.5K	0.27%	40
2024 Q4	$230K	Buy	+1,295	New	+$238K	0.22%	42

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Capstone Wealth Management (Alabama)'s ABBV Position: Q2 2026 in Review

Capstone Wealth Management (Alabama) increased its AbbVie (ABBV) stake by 2% in Q2 2026, buying an estimated $5.59K and bringing the position to 1,330 shares worth $335K. The position accounts for 0.16% of the portfolio, ranked #102.

Capstone Wealth Management (Alabama) first reported a position in ABBV in Q4 2024 and has held it in 7 quarters since. The position peaked at $335K in Q3 2025. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Capstone Wealth Management (Alabama) held 1,330 shares of AbbVie worth $335K as of Q2 2026.
Capstone Wealth Management (Alabama) bought 26 AbbVie shares in Q2 2026, an estimated $5.59K.
AbbVie made up 0.16% of Capstone Wealth Management (Alabama)'s portfolio in Q2 2026, its #102 holding.
Capstone Wealth Management (Alabama) first reported a position in AbbVie in Q4 2024 and has held it in 7 quarters since.
Capstone Wealth Management (Alabama)'s AbbVie position peaked at $335K in Q3 2025.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Capstone Wealth Management (Alabama)'s 13F filing for Q2 2026, filed 23 Jul 2026.